EZETIMIB ROSUVASTATIN MEPHA 10/40 mg cpr pell 90

7680684370083 CH-68437 C10BA06 07.12.0.

Active substances:

Ezetimibum Rosuvastatinum

No images available

Details

Product number
6843704
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
ezetimibum 10 mg, rosuvastatinum 40.0 mg ut rosuvastatinum calcicum, lactosum monohydricum 200.5 mg, carmellosum natricum conexum, povidonum K 29-32, natrii laurilsulfas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 5.04 mg, E 171, macrogolum 4000, pro compresso obducto corresp. natrium 3.02 mg.

Articles (1)

Ezetimib-Rosuvastatin-Mepha 10 mg / 40 mg, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
25/08/2026
Professional SmPC
Français
25/08/2026
Professional SmPC
Italien
25/08/2026
Patient information leaflet
Allemand
03/04/2026
Patient information leaflet
Français
03/04/2026
Patient information leaflet
Italien
03/04/2026

Detailed composition

Substance Quantity Type Category
ezetimibum
10.0 MG Substance Wirkstoff (Principe actif)
rosuvastatinum
40.0 MG Substance Wirkstoff (Principe actif)
rosuvastatinum calcicum
- Substance WIZUS
lactosum monohydricum
200.5 MG Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
povidonum K 29-32
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
cellulosum microcristallinum
- Substance HNIDK
hypromellosum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
lactosum monohydricum
5.04 MG Substance HBESI
E 171
- Substance FNIDK
macrogolum 4000
- Substance HNIDK
natrium
3.02 MG Substance HBESI

Reimbursement information

Public price
CHF 124.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2025

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68437
Drug name
Ezetimib-Rosuvastatin-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
C10BA06
Authorization status
Z
Dispensation category
B
First authorization
27/04/2022
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIB ROSUVASTATIN MEPHA 10/40 mg cpr pell 90
Description (DE)
EZETIMIB ROSUVASTATIN MEPHA 10/40 mg Filmtabl 90
Market launch
03/09/2025
Narcotic (BTM)
No

Other packaging sizes

EZETIMIB ROSUVAST Mepha cpr pell 10mg/5mg 30 pce
30 TABL
GTIN: 7680684370014
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/5mg 90 pce
90 TABL
GTIN: 7680684370021
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/10mg 30 pce
30 TABL
GTIN: 7680684370038
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/10mg 90 pce
90 TABL
GTIN: 7680684370045
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/20mg 30 pce
30 TABL
GTIN: 7680684370052
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/20mg 90 pce
90 TABL
GTIN: 7680684370069
View
EZETIMIB ROSUVASTATIN MEPHA 10/40 mg cpr pell 30
30 TABL
GTIN: 7680684370076
View
Buy us a coffee Explore the data